Zhongjun X. Ma

No. 1 Zheda Road
Zhoushan, 316021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Medium-chain substrate preference of lipases from a novel deep-sea halotolerant bacterium revealed by enzymatic assays and molecular docking.

Medium-chain substrate preference of lipases from a novel deep-sea halotolerant bacterium revealed by enzymatic assays and molecular docking.

Journal: International journal of biological macromolecules

Published: January 28, 2026

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Journal: Journal of medicinal chemistry

Published: January 23, 2026

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.

Journal: European journal of medicinal chemistry

Published: November 12, 2025

Experimental study on shear mechanical behavior of bolted rock joints and rock-bolt interaction mechanism.

Experimental study on shear mechanical behavior of bolted rock joints and rock-bolt interaction mechanism.

Journal: Scientific reports

Published: October 16, 2025

DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug Discovery.

DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug Discovery.

Journal: Journal of chemical information and modeling

Published: July 30, 2025

A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression.

A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression.

Journal: Acta pharmaceutica Sinica. B

Published: June 10, 2025

Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.

Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.

Journal: Journal of medicinal chemistry

Published: April 01, 2025

Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma

Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: December 02, 2024

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.

Journal: Journal of medicinal chemistry

Published: November 11, 2024

Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer.

Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer.

Journal: Journal of medicinal chemistry

Published: August 07, 2024

Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer.

Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer.

Journal: Journal of medicinal chemistry

Published: July 26, 2024

Respiratory adverse effects in patients treated with immune checkpoint inhibitors in combination with radiotherapy: a systematic review and meta-analysis.

Respiratory adverse effects in patients treated with immune checkpoint inhibitors in combination with radiotherapy: a systematic review and meta-analysis.

Journal: Radiation oncology (London, England)

Published: April 22, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026